As of Jul 31
| +0.47 / +0.93%|
The 9 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 100.00, with a high estimate of 155.00 and a low estimate of 63.00. The median estimate represents a +95.27% increase from the last price of 51.21.
The current consensus among 9 polled investment analysts is to Buy stock in PTC Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.